Showing results (1861-1870 of 4,733) with videos related to

Sort By:
Pageof 474
Drug Discovery Today|February 10, 2009
Clinical and economic impact of the nonresponder phenomenon--implications for systems based discoveryDavid B Jackson
Drug Discovery Today|July 11, 2008
Chemically modified siRNA: tools and applicationsJonathan K Watts, Glen F Deleavey, Masad J Damha
Drug Discovery Today|July 12, 2008
Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicineWilliam C Eckelman, Richard C Reba, Gary J Kelloff
Drug Discovery Today|July 16, 2008
Maintaining the silence: reflections on long-term RNAiKoen Raemdonck, Roosmarijn E Vandenbroucke, Joseph Demeester, et al.
Drug Discovery Today|June 27, 2008
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?Boris Cvek, Zdenek Dvorak
Drug Discovery Today|November 29, 2008
Is there a case for selectively promiscuous anticancer drugs?Ariel Fernández, Alejandro Crespo, Abhinav Tiwari
Drug Discovery Today|December 2, 2008
Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposityJosep M Argilés, Francisco J López-Soriano, Sílvia Busquets
Drug Discovery Today|November 26, 2008
Modelling iterative compound optimisation using a self-avoiding walkJohn Delaney
Drug Discovery Today|September 9, 2008
Metabolic engineering of microorganisms: general strategies and drug productionSang Yup Lee, Hyun Uk Kim, Jin Hwan Park, et al.
Drug Discovery Today|August 30, 2008
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drugLuigi Fiume, Michele Baglioni, Luigi Bolondi, et al.
Pageof 474